{
    "clinical_study": {
        "@rank": "53643", 
        "arm_group": {
            "arm_group_label": "platform-switch tapered internal implants", 
            "arm_group_type": "Other", 
            "description": "2 platform-switch tapered internal implants placed in 10 participants.clinical and radiographic assessment in 6,12,24, month post implant insertion"
        }, 
        "brief_summary": {
            "textblock": "1. To investigate the hard and soft tissue adaptation and maintenance to the Laser-Lok\u00ae\n           microchannels permanent abutment/ new Laser-Lok\u00ae  implant assembly by performing\n           clinical and radiographic evaluations.\n\n        2. To investigate the effect of inter-implant spacing (minimum of 2 or 3 mm) on hard and\n           soft tissues.\n\n        3. To perform clinical and radiographic evaluations on these abutment/implant assemblies\n           up to 2 years."
        }, 
        "brief_title": "A Prospective Clinical and Radiographic Assessment on New Platform-switched Laser Lok Implants", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Preserve Crestal Bone Level and Gingival Margin Around Dental Implants", 
        "detailed_description": {
            "textblock": "-  Screening (Inclusion/ Exclusion Criteria)\n\n        -  Day of Surgery: Dental CT scan/ periapical radiograph / clinical picture / clinical\n           examination (probing depth, BOP, gingival recession).\n\n        -  Implant Restoration Day: Post-restoration periapical radiograph/ clinical picture/\n           clinical examination (probing depth, BOP, gingival recession).\n\n        -  6 month, 1 Year and 2 Year Post Restoration:  periapical radiograph / clinical picture\n           / clinical examination (probing depth, BOP, gingival recession)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:1. Male or female, between 20-70 years of age, who request dental\n        implant treatment options for rehabilitation.\n\n        2. Subjects who are willing to sign an informed consent, participate and return for\n        follow-up visits.\n\n        3. Subjects without significant medical history and currently not on medications that\n        might complicate the results.\n\n        4. Subjects presenting with an edentulous area requiring a tooth-replacement option.\n\n        -\n\n        Exclusion Criteria:1. Subjects who do not meet all the inclusion criteria or who will not\n        cooperate with the protocol schedule.\n\n        2. Subjects who received and failed a previously placed dental implant. 3. Subjects who\n        require an onlay ridge augmentation procedure in the area to achieve adequate bone volume\n        for the placement of dental implants.\n\n        4. Subjects who have significant untreated periodontal disease, caries, infection or\n        chronic inflammation in the oral cavity within two adjacent tooth positions of the\n        clinical trial area.\n\n        5. Subjects who have used nicotine-containing products within 3 weeks prior to surgery.\n\n        6. Subjects who are insulin-dependent diabetic or if their Hgb1c levels > 6.5%. 7.\n        Subjects who have had a history of malignancy within the past 5 years (except for basal or\n        squamous cell carcinoma of the skin or in situ cervical carcinoma).\n\n        8. Subjects who are nursing or pregnant. 9. Subjects who are presently taking medications\n        (except estrogen/progesterone therapy) or those who are undergoing treatment that in known\n        to have an effect on bone turnover.\n\n        10. Subjects who have diseases that affect bone metabolism (excluding idiopathic\n        osteoporosis).\n\n        11. Subjects with a history of an autoimmune disease, documented allergy or multiple\n        allergies to any component of the agents used in this study.\n\n        12. Acutely infected defect site. 13. Immediate implant site.\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01899131", 
            "org_study_id": "TASMC 13 AS 177-13-TLV CTIL"
        }, 
        "intervention": {
            "arm_group_label": "platform-switch tapered internal implants", 
            "description": "Laser-Lok permanent abutment/ new Laser Lok platform-switch implant assembly.assessment at 6,12,24 month clinicaly and radiographic", 
            "intervention_name": "platform-switch tapered internal implants", 
            "intervention_type": "Device", 
            "other_name": "Biohorizons platform-switch tapered internal implants"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "dental implants", 
            "crestal bone", 
            "gingival margin"
        ], 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tel Aviv", 
                    "country": "Israel", 
                    "zip": "64239"
                }, 
                "name": "Tel Aviv Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective Clinical and Radiographic Assessment on New Platform-switched Laser Lok Implants", 
        "overall_contact": {
            "email": "amnons@tlvmc.gov.il", 
            "last_name": "Amnon Singer, DMD", 
            "phone": "+97236973676"
        }, 
        "overall_official": {
            "affiliation": "Tel Aviv Medical Center", 
            "last_name": "Amnon Singer, DMD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "prevent apical migration of the epithelial attachment, and preserve bone level around implant head. radiographic and clinical assessment during recall periods", 
            "measure": "epithelial attachment and bone level around implants", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01899131"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "preserve the coronal level of bone", 
            "measure": "inhibit the loss of crestal bone .", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Tel-Aviv Sourasky Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tel-Aviv Sourasky Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}